Postrandomization Confounding Challenges the Applicability of Randomized Clinical Trials in Comparative Effectiveness Research. - Wikidata - wikimedia - TriplyDB

Postrandomization Confounding Challenges the Applicability of Randomized Clinical Trials in Comparative Effectiveness Research.

Postrandomization Confounding Challenges the Applicability of Randomized Clinical Trials in Comparative Effectiveness Research.

http://www.wikidata.org/entity/Q33609058

about

Postrandomization Confounding Challenges the Applicability of Randomized Clinical Trials in Comparative Effectiveness Research.

http://www.wikidata.org/entity/Q33609058

description

2017 nî lūn-bûn

@nan

2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Postrandomization Confounding ...... rative Effectiveness Research.

@ast

Postrandomization Confounding ...... rative Effectiveness Research.

@en

type

label

Postrandomization Confounding ...... rative Effectiveness Research.

@ast

Postrandomization Confounding ...... rative Effectiveness Research.

@en

prefLabel

Postrandomization Confounding ...... rative Effectiveness Research.

@ast

Postrandomization Confounding ...... rative Effectiveness Research.

@en

P1433

Q33609058-97D8351D-BDE1-4FF6-A9B4-774BC651D0CF

P1476

Q33609058-A66A3901-DC8C-4853-9732-4A473A7CFE98

P2093

Q33609058-39BC4A97-3981-447F-9AFA-515020AAE72B

Q33609058-65D94A2D-1FE2-47D3-A04A-8AC64932105F

Q33609058-B941BD94-171C-4580-8059-AEA87D95B741

Q33609058-C5355DFF-051D-4AC6-A89F-D3B8ABE34B81

P2860

Q33609058-0E3CD4B0-D255-4FEB-87DA-449DF25259D4

Q33609058-0F6F9C28-ECE5-4344-B8CB-BEE17F6B2C96

Q33609058-14F6665F-640A-49D3-B5F1-99620DBE6553

Q33609058-336D94A9-BD5E-4C10-8AD7-8472EBC7078E

Q33609058-49357091-0FD1-4D34-BEBA-4546FF150CDE

Q33609058-733F968B-B5A7-47BC-96E6-FCA0C8C0A238

Q33609058-9E899038-A50C-4FFF-B831-C4137F748BAC

Q33609058-B3358313-1F0E-4EF8-A391-DE5044D78AFC

Q33609058-B3B31F49-A6A2-4BE3-B57C-73A2C12088B0

Q33609058-B669E11D-6EC3-4549-B457-C1FC82E3D990

P304

Q33609058-C6EA72EE-96C2-4F70-950E-F59E92F648BE

P31

Q33609058-8EA055BF-D283-4F42-A1B4-ADE97FEE1063

P356

Q33609058-94BAE2BA-33E9-4F4F-802A-8F8B0A87D0BB

P407

Q33609058-62A7E857-E358-4715-87AC-D33B2697BBC0

P433

Q33609058-31E9049C-3C06-4936-AE43-FE0FA07DE9B1

P478

Q33609058-63884CAC-2218-4A5A-8519-D9E15A4B9B6A

P577

Q33609058-22E565DD-CA0C-40A7-A7DA-C6D416D908CD

P698

Q33609058-63104DDA-F57F-4B87-ADC6-8EFE332459EC

P932

Q33609058-7CD3A107-C9B0-47F5-A009-763D2B00BC9A

P356

0366-6999.204117

P1433

Chinese Medical Journal

P1476

Postrandomization Confounding ...... rative Effectiveness Research.

@en

P2093

Jing-Jing Feng

http://www.w3.org/2001/XMLSchema#string

Xiao-Lu Nie

http://www.w3.org/2001/XMLSchema#string

Xiao-Xia Peng

http://www.w3.org/2001/XMLSchema#string

Ya-Guang Peng

http://www.w3.org/2001/XMLSchema#string

P2860

Sources of Heterogeneity in Trials Reporting Hydroxyethyl Starch 130/0.4 or 0.42 Associated Excess Mortality in Septic Patients: A Systematic Review and Meta-regression

Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin-angiotensin-aldosterone system inhibitors involving 158,998 patients

A Randomized Trial of Intensive versus Standard Blood-Pressure Control

2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

Telmisartan, ramipril, or both in patients at high risk for vascular events.

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).

2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Randomized trials analyzed as observational studies.

Angiotensin receptor blockers and risk of myocardial infarction: meta-analyses and trial sequential analyses of 147 020 patients from randomised trials.

P304

993-996

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/0366-6999.204117

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

130

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28397731

http://www.w3.org/2001/XMLSchema#string

P932

5407048

http://www.w3.org/2001/XMLSchema#string